文献速递糖尿病肥胖与代谢综合征

糖尿病患者心力衰竭的当代管理

Contemporary Management of Heart Failure in Patients With Diabetes.
PubMed 文献 · Diabetes Care · 2020-01-01

本综述概述了用于治疗心力衰竭或有心衰风险患者的当前疗法及其在糖尿病患者中的特殊作用,讨论了部分降糖药物在治疗伴或不伴糖尿病的心衰患者中的获益,并指出长病程老年1型糖尿病患者的心衰问题尚需进一步临床研究。

要点

  • 传统心衰疗法及部分新型药物可为糖尿病患者带来获益。
  • 部分新型降糖药可显著改善心衰症状、住院及死亡等心血管结局。
  • 长病程老年1型糖尿病患者的心衰问题研究尚不充分。

核心结论

  • 传统心衰疗法及部分新型药物对糖尿病患者有益,部分新型降糖药可带来显著心血管 morbidity 和 mortality 获益并明显改善心衰症状、住院及死亡。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 部分较新引入的2型糖尿病药物在心血管 morbidity 和 mortality 方面产生显著获益,并明显改善心衰症状、住院表现及死亡。
  • 长病程老年1型糖尿病患者中也可观察到心衰,但该临床问题未像2型糖尿病患者那样被广泛探索。

临床怎么用

  • 临床中应关注糖尿病患者的心衰风险,并考虑传统心衰疗法及部分新型降糖药物对心衰的潜在获益。

局限性

  • 长病程老年1型糖尿病患者的心衰问题尚未被广泛探索,需进一步临床研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Both heart failure and diabetes are increasing in prevalence in Western communities. The interrelationship between these two conditions is well known, with conventional heart failure therapies including several newer drug classes providing benefit to subjects with diabetes. Furthermore, several of the more recently introduced medications for type 2 diabetes have resulted in significant cardiovascular morbidity and mortality benefits with a marked improvement in heart failure symptoms and hospital presentations as well as deaths. This review outlines current therapies used to treat patients with or at risk for heart failure and their particular role in subjects with diabetes. Newer therapies, including certain glucose-lowering medications and their benefits in treating heart failure patients with and without diabetes, are also discussed. Finally, heart failure is also observed in long-duration, aging patients with type 1 diabetes, but this clinical issue has not been as extensively explored as in patients with type 2 diabetes and warrants further clinical investigation.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Shaw JA, Cooper ME. Contemporary Management of Heart Failure in Patients With Diabetes. Diabetes Care. 2020. PMID: 33218978. doi:10.2337/dc20-2173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。